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Understanding the spatial organization of gene expression with single-nucleotide resolution requires localizing the sequences of expressed RNA transcripts within a cell in situ. Here, we describe fluorescent in situ RNA sequencing (FISSEQ), in which stably cross-linked complementary DNA (cDNA) amplicons are sequenced within a biological sample. Using 30-base reads from 8102 genes in situ, we examined RNA expression and localization in human primary fibroblasts with a simulated wound-healing assay. FISSEQ is compatible with tissue sections and whole-mount embryos and reduces the limitations of optical resolution and noisy signals on single-molecule detection. Our platform enables massively parallel detection of genetic elements, including gene transcripts and molecular barcodes, and can be used to investigate cellular phenotype, gene regulation, and environment in situ.
T he spatial organization of gene expression can be observed within a single cell, tissue, and organism, but the existing RNA localization methods are limited to a handful of genes per specimen, making it costly and laborious to localize RNA transcriptome-wide (1-3). We originally proposed fluorescent in situ sequencing (FISSEQ) in 2003 and subsequently developed methods to sequence DNA amplicons on a solid substrate for genome and transcriptome sequencing (4-7); however, sequencing the cellular RNA in situ for gene expression profiling requires a spatially structured sequencing library and an imaging method capable of resolving the amplicons.
We report here the next generation of FISSEQ. To generate cDNA amplicons within the cell ( fig.  S1 ), RNA was reverse-transcribed in fixed cells with tagged random hexamers ( fig. S2A ). We incorporated aminoallyl deoxyuridine 5′-triphosphate (dUTP) during reverse transcription (RT) ( fig. S2B ) and refixed the cells using BS(PEG)9, an aminereactive linker with a 4-nm spacer. The cDNA fragments were then circularized before rolling circle amplification (RCA) ( fig. S2C ), and BS (PEG)9 was used to cross-link the RCA amplicons containing aminoallyl dUTP (fig. S2, D and E). We found that random hexamer-primed RT was inefficient ( fig. S3A ), but cDNA circularization was complete within hours ( fig. S3 , B to D). The result was single-stranded DNA nanoballs 200 to 400 nm in diameter ( fig. S4A ), consisting of numerous tandem repeats of the cDNA sequence. BS(PEG)9 reduced nonspecific probe binding ( fig. S4B ), and amplicons were highly fluorescent after probe hybridization ( fig. S4C) . As a result, the amplicons could be rehybridized many times, with minimal changes in their signal-to-noise ratio or position ( fig. S4 , D and E). Using SOLiD sequencing by ligation ( fig. S5) , the signal overlap over 27 consecutive sequencing reactions was 600 nm in diameter ( fig. S4F ). In induced pluripotent stem (iPS) cells, the amplicons counterstained subcellular structures, such as the plasma membrane, the nuclear membrane, the nucleolus, and the chromatin (Fig. 1A, fig. S6 , and movies S1 to S3 sections, and whole-mount embryos for threedimensional (3D) visualization that spanned multiple resolution scales (Fig. 1, B and C) .
High numerical aperture and magnification are essential for imaging RNA molecules in single cells (8) (9) (10) , but many gene expression patterns are most efficiently detected in a low-magnification and wide-field mode, where it typically becomes difficult to distinguish single molecules because of the optical diffraction limit and low sensitivity (11) . To obtain a spot density that is high enough to yield statistically significant RNA localization, and yet sufficiently low for discerning individual molecules, we developed partition sequencing, in which preextended sequencing primers are used to reduce the number of molecular sequencing reactions through random mismatches at the ligation site ( Fig. 2A) . Progressively longer sequencing primers result in exponential reduction of the observed density, and the sequencing primer can be changed during imaging to detect amplicon pools of different density.
Fluorescence microscopy can be accompanied by tissue-specific artifacts and autofluorescence, which impede accurate identification of objects. If objects are nucleic acids, however, discrete sequences, rather than the analog signal intensity, can be used to analyze the image. For FISSEQ, putative nucleic acid sequences are determined for all pixels. The sequencing reads are then compared with reference sequences, and a null value is assigned to unaligned pixels. With a suitably long read length (L), a large number of unique sequences (n) can be used to identify transcripts or any other objects with a false-positive rate of approximately n/4 L per pixel. Because the intensity threshold is not used, even faint objects are registered on the basis of their sequence, whereas background noise, autofluorescence, and debris are eliminated (Fig. 2B) .
We applied these concepts to sequence the transcription start site of inducible mCherry mRNA in situ, analogous to 5′ rapid amplification of cDNA ends-polymerase chain reaction (RACE-PCR) (12) . After RT and molecular amplification of the 5′ end followed by fluorescent probe hybridization ( fig. S7A) , we quantified the concentrationand time-dependent mCherry gene expression in situ (fig. S7B ). Using sequencing-by-ligation, we then determined the identity of 15 contiguous bases from each amplicon in situ, corresponding to the transcription start site ( fig. S7C ). When the sequencing reads were mapped to the vector sequence, 7472 (98.7% ) amplicons aligned to the positive strand of mCherry, and 3967 (52.4%) amplicons mapped within two bases of the predicted transcription start site ( fig. S7D) .
We then sequenced the transcriptome in human primary fibroblasts in situ (Fig. 3A) and generated sequencing reads of 27 bases with a median per-base error rate of 0.64% ( fig. S8) . Using an automated analysis pipeline ( fig. S9) , we identified 14,960 amplicons with size >5 pixels, representing 4171 genes, of which 13,558 (90.6%) amplicons mapped to the correct annotated strand (Fig. 3B,  fig. S10 , and table S1). We found that mRNA (43.6%) was relatively abundant even though random hexamers were used for RT (Fig. 3C ). Ninety genes with the highest expression counts included fibroblast markers (13), such as fibronectin (FN1); collagens (COL1A1, COL1A2, COL3A1); matrix metallopeptidases and inhibitors (MMP14, MMP2, TIMP1); osteonectin (SPARC); stanniocalcin (STC1); and the bone morphogenesis-associated transforming growth factor (TGF)-induced protein (TGFBI), representing extracellular matrix, bone development, and skin development [Benjamini-Hochberg false discovery rate (FDR) <10 −19 , 10
, and 10
, respectively] (Fig. 3D) (14) . We made Illumina sequencing libraries to compare FISSEQ to RNAseq. Pearson's r correlation coefficient between RNA-seq and FISSEQ ranged from 0.52 to 0.69 (P < 10 ) between FISSEQ and RNA-seq from fibroblasts, lymphocytes, and iPS cells, respectively (Fig. 3E) . When FISSEQ was compared with gene expression arrays, Pearson's r was as high as 0.73 (P < 10
) among moderately expressed genes, whereas genes with low or high expression levels correlated poorly (r < 0.4) (fig. S11) . L per pixel, where n is the size of the reference. By removing unaligned pixels, the nuclear background noise is reduced in fibroblasts (scale bar: 20 mm).
www.sciencemag.org SCIENCE VOL 343 21 MARCH 2014
Highly abundant genes in RNA-seq and gene expression arrays were involved in translation and splicing (figs. S11 and S12), whereas such genes were underrepresented in FISSEQ. We examined 12,427 (83.1%) and 2533 (16.9%) amplicons in the cytoplasm and nuclei, respectively, and found that nuclear RNA was 2.1 [95% confidence interval (CI) 1.9 to 2.3] times more likely to be noncoding (P < 10
), and antisense mRNA was 1.8 [95% CI 1.7 to 2.0] times more likely to be nuclear (P < 10
−16
). We confirmed nuclear enrichment of MALAT1 and NEAT1 by comparing their relative distribution against all RNAs (Fig. 3F) or mitochondrial 16S ribosomal RNA (rRNA) (table S2), whereas mRNA, such as COL1A1, COL1A2, and THBS1, localized to the cytoplasm (table S3) . We also examined splicing junctions of FN1, given its high read coverage (481 reads over 8.9 kilobases). FN1 has three variable domains referred to as EDA, EDB, and IIICS, which are alternatively spliced (15) . We did not observe developmentassociated EDB, but observed adult tissueassociated EDA and IIICS (Fig. 3G) .
We also sequenced primary fibroblasts in situ after simulating a response to injury, obtaining 156,762 reads (>5 pixels), representing 8102 annotated genes (Fig. 4A and fig S13, A to D) . Pearson's r was 0.99 and 0.91 between different wound sites and growth conditions, respectively (Fig. 4B and fig. S13, E and F) . In medium with epidermal growth factor (EGF), 82.7% of the amplicons were rRNA compared to 42.7% in fetal bovine serum (FBS) medium. When the 100 highest ranked genes were clustered, cells in FBS medium were enriched for fibroblast-associated GO terms, whereas rapidly dividing cells in EGF medium were less fibroblast-like (Fig. 4C ) with alternative splicing of FN1 (fig. S14 ). In regions containing migrating cells versus contact-inhibited cells, 12 genes showed differences in relative gene expression (Fisher's exact test P < 0.05 and >fivefold change) (Fig. 4 , D to F, and table S4), eight of which were associated with the extracellular matrix (ECM)-receptor-cytoskeleton interaction, including GID4, FHDC1, PRPF40A, LMO7, and WNK1 ( Fig. 4G and table S4 ).
In summary, we present a platform for transcriptome-wide RNA sequencing in situ and demonstrate imaging and analytic approaches across multiple specimen types and spatial scales. FISSEQ correlates well with RNA-seq, except for genes involved in RNA and protein processing, possibly because some cellular structures or classes of RNA are less accessible to FISSEQ. It is notable that FISSEQ generates far fewer reads than RNA-seq but predominantly detects genes characterizing cell type and function. If this finding can be generalized, FISSEQ may be used to identify cell types based on gene expression profiles in situ. Using partition sequencing to control the signal density, it may even be possible to combine transcriptome profiling and in situ mutation detection in a high-throughput manner (16) (17) (18) . Using RNA barcodes from expression vectors, one can label up to 4 N (N = barcode length) cells uniquely, much more than is possible using a combination of fluorescent proteins (19) . Similar to next-generation sequencing, we expect advances in read length, sequencing depth and coverage, and library preparation (i.e., fragmentation, rRNA depletion, targeted sequencing). Such advances may lead to improved stratification of diseased tissues in clinical medicine. Although more work remains, our present demonstration is an important first step toward a new era in biology and medicine.
